Funding to support lead candidate targeting FAP and pipeline expansion

New trial to test VMX-C001’s effectiveness in restoring coagulation in FXa DOAC patients

Enter the 2025 PharmaTimes Clinical Researcher of the Year – The Americas

PulseSight begins phase 1 safety study of gene therapy for geographic atrophy

SMC approval provides option for postmenopausal women at risk of fractures

CSL Behring marks new era in treatment with milestone reimbursement model

Pneumagen’s intranasal antiviral demonstrates reduced infection

Data shows mRNA-1010 could better protect adults aged 50 and above

Positive trial results offer hope for those with ultra-rare epileptic disorder

New data show strong efficacy of CD388 in phase 2b trial